HomeCompareEPGNF vs STAG

EPGNF vs STAG: Dividend Comparison 2026

EPGNF yields 178.57% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EPGNF wins by $62.90M in total portfolio value
10 years
EPGNF
EPGNF
● Live price
178.57%
Share price
$1.12
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62.91M
Annual income
$29,936,192.20
Full EPGNF calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.09
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.22
Full STAG calculator →

Portfolio growth — EPGNF vs STAG

📍 EPGNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEPGNFSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EPGNF + STAG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EPGNF pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EPGNF
Annual income on $10K today (after 15% tax)
$15,178.57/yr
After 10yr DRIP, annual income (after tax)
$25,445,763.37/yr
STAG
Annual income on $10K today (after 15% tax)
$292.45/yr
After 10yr DRIP, annual income (after tax)
$392.89/yr
At 15% tax rate, EPGNF beats the other by $25,445,370.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EPGNF + STAG for your $10,000?

EPGNF: 50%STAG: 50%
100% STAG50/50100% EPGNF
Portfolio after 10yr
$31.47M
Annual income
$14,968,327.21/yr
Blended yield
47.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

EPGNF
No analyst data
Altman Z
-10.1
Piotroski
3/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.7% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EPGNF buys
0
STAG buys
0
No recent congressional trades found for EPGNF or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEPGNFSTAG
Forward yield178.57%3.44%
Annual dividend / share$2.00$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3%
Portfolio after 10y$62.91M$18.3K
Annual income after 10y$29,936,192.20$462.22
Total dividends collected$58.90M$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: EPGNF vs STAG ($10,000, DRIP)

YearEPGNF PortfolioEPGNF Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$28,557$17,857.14$10,665$345.09+$17.9KEPGNF
2$78,215$47,658.78$11,364$357.70+$66.9KEPGNF
3$205,683$121,992.76$12,098$370.43+$193.6KEPGNF
4$519,899$299,818.53$12,869$383.28+$507.0KEPGNF
5$1,264,557$708,265.17$13,677$396.23+$1.25MEPGNF
6$2,963,097$1,610,021.03$14,524$409.27+$2.95MEPGNF
7$6,696,294$3,525,779.94$15,411$422.41+$6.68MEPGNF
8$14,611,669$7,446,634.50$16,339$435.61+$14.60MEPGNF
9$30,820,422$15,185,936.42$17,311$448.89+$30.80MEPGNF
10$62,914,044$29,936,192.20$18,327$462.22+$62.90MEPGNF

EPGNF vs STAG: Complete Analysis 2026

EPGNFStock

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.

Full EPGNF Calculator →

STAGREIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this EPGNF vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EPGNF vs SCHDEPGNF vs JEPIEPGNF vs OEPGNF vs KOEPGNF vs MAINEPGNF vs PLDEPGNF vs EQREPGNF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.